Cat Kidney Disease: Early Signs, Staging, Treatment Goals, and Daily Care

Chronic kidney disease (CKD) is the most common metabolic disorder of older cats, affecting an estimated 30 to 40 percent of cats over 10 years of age. It is a progressive, irreversible condition in which the kidneys lose their ability to filter waste, regulate electrolytes, and produce hormones essential for red blood cell production and blood pressure control. This article provides a definitive, evidence-based overview covering early detection, the International Renal Interest Society (IRIS) staging system, treatment goals, and practical daily care strategies. It draws on peer-reviewed research and consensus guidelines to help veterinary professionals and cat owners navigate this complex disease.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance: Key Facts About Feline CKD

Understanding the Feline Kidney: Anatomy and Physiology

The feline kidney is a paired, bean-shaped organ located retroperitoneally in the dorsal abdomen. Each kidney contains approximately 200,000 nephrons, the functional units responsible for filtration, reabsorption, and secretion. The glomerulus filters blood, producing an ultrafiltrate that is then modified along the tubules. The proximal tubule reabsorbs glucose, amino acids, and electrolytes. The loop of Henle concentrates urine. The distal tubule and collecting duct fine-tune electrolyte balance and acid-base status under hormonal control.

In CKD, progressive nephron loss forces surviving nephrons to hyperfilter, which initially maintains glomerular filtration rate (GFR) but eventually accelerates injury. The most common histopathological finding is tubulointerstitial fibrosis, characterised by extracellular matrix accumulation, tubular atrophy, and interstitial inflammation [6]. This fibrotic process is the final common pathway for nearly all progressive kidney diseases in cats [6].

Causes and Risk Factors for Feline CKD

Primary Causes

The aetiology of feline CKD is often unknown (idiopathic). However, several contributing factors have been identified:

• Tubulointerstitial fibrosis: The most common pathological diagnosis, driven by chronic inflammation, oxidative stress, and hypoxia [6].
• Ischaemic injury: A single renal ischaemic event can trigger progressive fibrosis and glomerulosclerosis, leading to sustained creatinine elevation and GFR reduction over months [9].
• Polycystic kidney disease (PKD): An autosomal dominant condition caused by a c.10063C>A mutation in the PKD1 gene, highly prevalent in Persian and related breeds [11]. Affected cats develop multiple renal cysts that gradually replace functional tissue [16].
• Infectious agents: Feline morbillivirus (FeMV) has been associated with tubulointerstitial nephritis, though its causal role in azotaemic CKD remains uncertain [5]. Feline foamy virus (FFV) infection can produce mild renal changes, but an overt association with CKD has not been statistically confirmed [1].
• Nephrotoxins: Exposure to lilies (Lilium and Hemerocallis species), non-steroidal anti-inflammatory drugs (NSAIDs), aminoglycosides, and ethylene glycol can cause acute kidney injury that may transition to chronic disease.

Risk Factors

• Age: The strongest predictor. CKD prevalence rises steeply after 9 years of age [10].
• Breed: Persians, Himalayans, and other brachycephalic breeds are predisposed to PKD [11]. Siamese cats may have familial renal failure [11].
• Sex: Some studies report a higher prevalence in males, though this is not consistent across all populations [1].
• Dental disease: Periodontal disease is associated with systemic inflammation that may contribute to renal injury.
• Diet: High-phosphorus diets accelerate progression in cats with existing CKD.

Early Signs of Cat Kidney Disease: What Owners Should Watch For

Early CKD is clinically silent because the kidneys have substantial functional reserve. Signs typically appear only after approximately 75% of nephron function is lost. Owners may notice subtle changes that are easily attributed to normal aging.

The Classic Triad: PU/PD, Weight Loss, Poor Coat

• Polyuria and polydipsia (PU/PD): The earliest and most common signs. Cats drink more water and produce larger volumes of dilute urine. A cat drinking more than 100 mL/kg/day or producing urine with a specific gravity below 1.035 warrants investigation.
• Weight loss and muscle wasting: Reduced appetite, metabolic acidosis, and protein catabolism contribute to progressive weight loss.
• Poor coat quality: Unkempt, greasy, or matted fur due to decreased grooming from lethargy or nausea.

Gastrointestinal Signs

• Vomiting and nausea: Uraemic toxins stimulate the chemoreceptor trigger zone. Cats may show subtle signs such as lip-licking, drooling, or hiding food.
• Anorexia and picky eating: Reduced appetite is common, often fluctuating from day to day.
• Constipation: CKD cats have significantly lower defecation frequency compared to healthy cats. A survey found 42% of CKD cats defecated less than once daily, compared to 15% of healthy cats [8].

Systemic Signs

• Lethargy and weakness: Anaemia, metabolic acidosis, and uraemia contribute to reduced activity.
• Halitosis: Uraemic breath has a characteristic ammoniacal odour from urea breakdown in saliva.
• Oral ulcerations: Uraemic stomatitis can cause painful lesions on the tongue, gums, and buccal mucosa.
• Hypertension-related signs: Sudden blindness (from retinal detachment or intraocular haemorrhage), behavioural changes, or seizures may indicate hypertensive crisis.

Emergency Red Flags

• Inability to urinate: Suggests urinary obstruction, which is a medical emergency.
• Sudden collapse or weakness: May indicate severe anaemia, hyperkalaemia, or hypertensive crisis.
• Seizures or blindness: Urgent blood pressure assessment is needed.
• Complete anorexia for more than 24 hours: Risk of hepatic lipidosis.
• Severe dehydration: Skin tenting, sunken eyes, dry mucous membranes.

Diagnosis: From Suspicion to Confirmation

Physical Examination

Veterinarians may detect:

• Small, irregular kidneys on abdominal palpation (in advanced CKD)
• Enlarged kidneys (in PKD, hydronephrosis, or neoplasia)
• Pale mucous membranes (anaemia)
• Thin body condition and muscle atrophy
• Hypertension (systolic blood pressure > 160 mmHg)
• Oral ulcers or uraemic breath

Laboratory Diagnostics

Serum biochemistry:

• Creatinine: The most commonly used marker of GFR. However, it is insensitive to early disease because it only rises after 75% nephron loss.
• SDMA (symmetric dimethylarginine): A more sensitive biomarker that can detect CKD months earlier than creatinine. It is not affected by muscle mass.
• Blood urea nitrogen (BUN): Elevates with decreased GFR but is influenced by diet, gastrointestinal bleeding, and hydration.
• Phosphorus: Elevated in advanced CKD; hyperphosphataemia is a key driver of disease progression.
• Potassium: Hypokalaemia is common in cats with CKD due to urinary losses.
• Calcium: May be normal, elevated, or low; ionised calcium is preferred.
• Total thyroxine (T4): Hyperthyroidism can mask CKD by increasing GFR; T4 should be assessed in older cats.

Urinalysis:

• Urine specific gravity (USG): Inappropriately dilute urine (USG < 1.035) in a dehydrated cat is a hallmark of CKD.
• Urine protein:creatinine ratio (UPC): Proteinuria is a negative prognostic indicator. A UPC > 0.2 in cats warrants investigation [13].
• Urine sediment: May reveal casts, crystals, or evidence of urinary tract infection.

Complete blood count:

• Non-regenerative anaemia: Common in advanced CKD due to reduced erythropoietin production.
• Leukocytosis: May indicate concurrent infection.

Imaging

• Abdominal ultrasound: Can assess kidney size, shape, echogenicity, and corticomedullary distinction. It can detect cysts (PKD), nephroliths, hydronephrosis, and neoplasia.
• Radiography: Useful for detecting radiopaque nephroliths or ureteroliths.

IRIS Staging

The International Renal Interest Society (IRIS) staging system provides a standardised framework for classifying CKD severity and guiding treatment. Staging is based on fasting serum creatinine and SDMA measured on two or more occasions in a stable, well-hydrated cat.

IRIS Stages Based on Serum Creatinine:

SDMA-Based Staging (for early detection):

Substaging:

• Proteinuria substage: Based on UPC:
  • Non-proteinuric (NP): UPC < 0.2
  • Borderline proteinuric (BP): UPC 0.2 – 0.4
  • Proteinuric (P): UPC > 0.4
• Blood pressure substage: Based on systolic blood pressure (SBP):
  • Normotensive (NT): SBP < 140 mmHg
  • Borderline hypertensive (BH): SBP 140 – 159 mmHg
  • Hypertensive (HT): SBP 160 – 179 mmHg
  • Severely hypertensive (SHT): SBP ≥ 180 mmHg

Treatment Goals by IRIS Stage

Treatment goals evolve with disease progression. The overarching aims are to slow progression, manage complications, maintain quality of life, and address owner concerns.

Stage 1 (Non-azotaemic CKD)

Goal: Identify and address underlying causes; slow progression.

• Diet: Transition to a renal-friendly diet (restricted phosphorus, moderate protein, omega-3 fatty acids) even before azotaemia develops.
• Hydration: Ensure constant access to fresh water; consider wet food to increase water intake.
• Monitor: Recheck creatinine, SDMA, USG, UPC, and blood pressure every 3-6 months.
• Address proteinuria: If UPC > 0.4, consider ACE inhibitors (e.g., benazepril) or angiotensin receptor blockers (e.g., telmisartan) [13].
• Treat hypertension: If SBP > 160 mmHg consistently, initiate amlodipine.
• Dental care: Treat periodontal disease to reduce systemic inflammation.

Stage 2 (Mild Azotaemia)

Goal: Maintain stability; manage early complications.

• Diet: Renal diet is strongly recommended. Monitor phosphorus intake.
• Phosphate binders: If serum phosphorus exceeds 4.5 mg/dL despite dietary restriction, add intestinal phosphate binders (e.g., aluminium hydroxide, calcium carbonate, lanthanum carbonate).
• Potassium supplementation: If hypokalaemic (K+ < 3.5 mEq/L), supplement with potassium gluconate or potassium citrate.
• Hydration support: Consider subcutaneous fluids if dehydration is detected.
• Monitor: Every 3 months.

Stage 3 (Moderate Azotaemia)

Goal: Manage uraemic signs; treat complications aggressively.

• Diet: Strict renal diet. Appetite stimulants (e.g., mirtazapine, capromorelin) may be needed.
• Phosphate management: Target serum phosphorus < 5.0 mg/dL. Use binders aggressively.
• Anaemia management: If haematocrit < 20-25% and clinical signs present, consider darbepoetin alfa or molidustat (a hypoxia-inducible factor prolyl hydroxylase inhibitor) [7].
• Acid-base balance: Metabolic acidosis (low serum bicarbonate) may require oral sodium bicarbonate.
• Nausea and vomiting: Use antiemetics (maropitant, ondansetron, mirtazapine).
• Subcutaneous fluids: Regular administration (e.g., 100-150 mL every 1-3 days) helps maintain hydration and reduce uraemic toxins.
• Monitor: Every 1-2 months.

Stage 4 (Severe Azotaemia)

Goal: Palliative care; maintain quality of life.

• Intensive medical management: As per Stage 3, with more aggressive fluid therapy and appetite support.
• Hospitalisation: For acute decompensation, severe uraemia, or electrolyte disturbances.
• Dialysis: Haemodialysis is available at select referral centres but is rarely pursued due to cost and limited availability.
• Euthanasia: When quality of life is unacceptable despite maximal therapy.

Evidence-Based Management of Key Complications

Hyperphosphataemia

Hyperphosphataemia is a major driver of CKD progression and is independently associated with mortality. Management involves dietary phosphorus restriction and, if insufficient, intestinal phosphate binders. The IRIS target is serum phosphorus < 4.5 mg/dL in Stage 2, < 5.0 mg/dL in Stage 3, and < 6.0 mg/dL in Stage 4.

Proteinuria

Persistent proteinuria (UPC > 0.4) is a negative prognostic indicator [13]. The standard of care involves:

• Angiotensin-converting enzyme inhibitors (ACEi): benazepril (0.5-1.0 mg/kg PO q24h)
• Angiotensin receptor blockers (ARB): telmisartan (1 mg/kg PO q24h)
• Blood pressure control
• Dietary protein restriction (but not to the point of malnutrition)

Hypertension

Systemic hypertension affects 20-30% of cats with CKD. Untreated hypertension accelerates renal injury and causes target organ damage (eyes, brain, heart). First-line therapy is amlodipine (0.625-1.25 mg/cat PO q24h, titrated to effect). ACE inhibitors or ARBs may be added if proteinuria is present.

Anaemia

Anaemia of CKD is primarily due to insufficient erythropoietin production. Treatment options include:

• Darbepoetin alfa: A long-acting erythropoiesis-stimulating agent (ESA), dosed at 1 μg/kg SC once weekly initially, then tapered.
• Molidustat: A novel oral HIF-PH inhibitor that stimulates endogenous erythropoietin production. In a placebo-controlled trial, molidustat (5 mg/kg PO q24h) significantly increased haematocrit in anaemic CKD cats by Day 21 [7].
• Blood transfusion: For severe, life-threatening anaemia.

Hypokalaemia

Hypokalaemia exacerbates renal dysfunction and causes muscle weakness. Supplement with potassium gluconate (2-6 mEq/cat/day) or potassium citrate (which also provides alkalinisation).

Metabolic Acidosis

Acidosis promotes muscle wasting and bone demineralisation. Target serum bicarbonate > 18 mEq/L. Supplement with sodium bicarbonate (8-12 mg/kg PO q8-12h) or potassium citrate.

Constipation

CKD cats are prone to constipation due to dehydration and reduced colonic motility. Management includes:

• Increased water intake (wet food, flavoured water, water fountains)
• Subcutaneous fluids
• Fibre supplementation (psyllium, pumpkin)
• Osmotic laxatives (lactulose, 0.5-1.0 mL/kg PO q8-12h)
• Stool softeners (docusate sodium)

Daily Care: Practical Recommendations for Owners

Nutrition

• Renal diet: Prescription renal diets are formulated with restricted phosphorus, moderate protein, increased omega-3 fatty acids, and added B vitamins and potassium. Transition slowly over 7-10 days.
• Feeding strategy: Offer small, frequent meals. Warm food to enhance aroma. Use appetite stimulants if needed.
• Avoid: High-protein treats, high-phosphorus foods (cheese, dairy, organ meats), and raw diets.

Hydration

• Water sources: Multiple bowls (ceramic or stainless steel), water fountains, ice cubes.
• Wet food: Canned or pouch food provides approximately 80% moisture.
• Subcutaneous fluids: Administered by owners at home under veterinary guidance. Typical dose: 100-150 mL of lactated Ringer's solution or Normosol-R every 1-3 days.

Litter Box Management

• Frequency: CKD cats defecate less frequently than healthy cats [8]. Monitor bowel movements and report changes.
• Box placement: Easy access, quiet location, low-sided boxes for arthritic cats.
• Cleanliness: Scoop daily; change litter frequently to encourage use.

Medication Administration

• Pilling: Use pill pockets, treat-dispensing toys, or compounding pharmacies for flavoured liquids.
• Transdermal gels: Available for some drugs (e.g., mirtazapine, methimazole), but absorption is variable.
• Consistency: Administer medications at the same time daily.

Monitoring at Home

• Weight: Weekly weighing using a baby scale. A 5% loss over a month warrants veterinary attention.
• Appetite: Track daily food intake.
• Water intake: Measure daily water consumption.
• Urination: Note frequency, volume, and any straining or blood.
• Behaviour: Lethargy, hiding, or vocalisation may indicate pain or nausea.

Unsafe Home Remedies and Common Myths

• "Low-protein diet cures kidney disease": Protein restriction slows progression but does not reverse damage. Excessive restriction leads to malnutrition.
• "Apple cider vinegar alkalises the blood": No evidence supports this; it may cause gastrointestinal upset.
• "Human kidney supplements are safe": Many contain herbs or high phosphorus levels that are harmful.
• "Fluids can be given indefinitely without vet supervision": Overhydration can cause fluid overload and pulmonary oedema.
• "CKD cats should never eat treats": Low-phosphorus treats (e.g., small pieces of cooked chicken, freeze-dried meat) are acceptable in moderation.

Prevention and Early Detection

• Annual wellness screening: For all cats over 7 years, include serum biochemistry (creatinine, SDMA, phosphorus), urinalysis (USG, UPC), and blood pressure measurement.
• Breed screening: Persian and related breeds should be screened for PKD via ultrasound or genetic testing before breeding [11].
• Dental prophylaxis: Regular dental cleaning reduces systemic inflammatory burden.
• Avoid nephrotoxins: Keep lilies out of the home; use NSAIDs only under veterinary guidance.
• Weight management: Obesity is a risk factor for hypertension and diabetes, both of which stress the kidneys.

Prognosis

Prognosis depends on IRIS stage at diagnosis, proteinuria status, blood pressure control, and response to therapy. Median survival times from diagnosis are approximately:

• Stage 2: 2-3 years
• Stage 3: 1-2 years
• Stage 4: 3-6 months

Independent predictors of shorter survival include higher plasma creatinine, higher FGF-23 concentration, higher UPC, lower PCV, and older age [15]. Machine learning algorithms using creatinine at 48 hours and spontaneous feeding status can predict short-term survival in acute-on-chronic kidney disease [4].

The Diagnostic Workup: What to Expect at the Veterinary Visit

When a cat presents with signs suggestive of kidney disease, the veterinary team follows a systematic diagnostic pathway that extends well beyond basic bloodwork. Understanding this workflow helps owners prepare for the visit and appreciate why multiple tests may be needed before a definitive diagnosis and stage assignment can be made.

Initial Assessment and History Taking

The diagnostic process begins with a thorough history. Owners should be prepared to answer questions about their cat's water intake, urination frequency and volume, appetite changes, vomiting episodes, weight trends, and any medications or supplements the cat receives. A detailed dietary history is equally important, including the type and brand of food, treats, and any table foods offered. The veterinarian will also inquire about the cat's environment, including access to lilies or other potential nephrotoxins, and any history of urinary tract infections or previous episodes of acute kidney injury.

The Importance of Serial Measurements

A single set of laboratory values is rarely sufficient to diagnose and stage CKD definitively. The IRIS staging system requires that creatinine and SDMA be measured on at least two occasions in a stable, well-hydrated cat, ideally 1 to 2 weeks apart. This is because transient factors such as dehydration, stress, or recent meals can temporarily elevate creatinine and BUN, leading to overestimation of disease severity. Conversely, muscle wasting in older cats can lower baseline creatinine, potentially masking the degree of renal impairment. SDMA is less affected by muscle mass but can still fluctuate with hydration status and concurrent illness.

Urine Culture: An Often-Overlooked Diagnostic Step

While routine urinalysis provides valuable information about urine concentrating ability and proteinuria, a urine culture is essential in cats with CKD. Lower urinary tract infections are more common in CKD cats due to dilute urine, which reduces the natural antibacterial activity of concentrated urine. Additionally, CKD cats may have compromised immune function that predisposes them to bacterial colonization. A positive urine culture in the absence of pyuria or bacteriuria is not uncommon in this population. Untreated urinary tract infections can accelerate CKD progression and contribute to systemic inflammation. Therefore, a urine culture should be performed at initial diagnosis and periodically thereafter, particularly if the cat shows clinical signs such as inappropriate urination, hematuria, or worsening azotemia without an obvious cause.

Blood Pressure Measurement: Technique and Interpretation

Accurate blood pressure measurement is critical for proper staging and management of feline CKD. The standard technique involves using a Doppler ultrasonic flow detector with a cuff placed on the forelimb or tail. The cat should be allowed to acclimate to the examination room for 5 to 10 minutes before measurement, and the first reading should be discarded to account for stress-induced elevation. A minimum of five to seven consecutive readings should be obtained, and the average of the last three to five readings is used for clinical decision-making. Systolic blood pressure consistently above 160 mmHg warrants intervention, while readings between 140 and 159 mmHg are considered borderline and require monitoring. Owners should be aware that a single elevated reading does not confirm hypertension; repeated measurements over multiple visits are often needed to establish a diagnosis.

Imaging Beyond Ultrasound

While abdominal ultrasound is the imaging modality of choice for evaluating kidney architecture, additional imaging may be indicated in certain situations. Radiography can detect radiopaque nephroliths or ureteroliths that may not be visible on ultrasound. In cats with suspected ureteral obstruction, intravenous pyelography or computed tomography may be necessary to confirm the diagnosis and guide surgical or interventional management. Advanced imaging is particularly important in cats with acute-on-chronic kidney disease, where obstruction is a potentially reversible cause of decompensation.

Clinical Reasoning: Interpreting Laboratory Trends

Creatinine Versus SDMA: Complementary Biomarkers

The relationship between creatinine and SDMA provides valuable clinical insights. Creatinine is a byproduct of muscle metabolism and is filtered by the glomerulus. Its serum concentration is influenced by muscle mass, dietary protein intake, and hydration status. SDMA is a methylated arginine derivative that is also filtered by the glomerulus but is not affected by muscle mass or diet. In early CKD, SDMA may become elevated while creatinine remains within the reference range, allowing for earlier detection. However, SDMA can also be elevated in conditions other than CKD, such as hyperthyroidism, where increased GFR may lower creatinine while SDMA remains elevated due to increased protein turnover. Therefore, both biomarkers should be interpreted together, and an elevated SDMA with normal creatinine should prompt further investigation rather than an immediate diagnosis of CKD.

The Role of Fibroblast Growth Factor-23

Fibroblast growth factor-23 (FGF-23) is a phosphaturic hormone that becomes elevated early in CKD, often before hyperphosphatemia develops. FGF-23 promotes urinary phosphate excretion by inhibiting renal tubular reabsorption. However, as CKD progresses, the kidneys become resistant to FGF-23, leading to phosphate retention and hyperphosphatemia. Elevated FGF-23 concentration is independently associated with shorter survival time in cats with CKD, even after adjusting for creatinine, proteinuria, and blood pressure [15]. While FGF-23 measurement is not yet part of routine clinical practice, it is increasingly used in referral settings to identify cats at highest risk for rapid progression and to guide the intensity of phosphate restriction therapy.

The Challenge of Concurrent Disease

Feline CKD rarely occurs in isolation, particularly in older cats. Hyperthyroidism is a common comorbidity that can complicate the diagnosis and management of CKD. Hyperthyroidism increases GFR, which can lower serum creatinine and mask underlying renal impairment. Conversely, treatment of hyperthyroidism with methimazole or radioactive iodine can unmask CKD by reducing GFR and causing a rise in creatinine. Therefore, all cats diagnosed with hyperthyroidism should have their renal function reassessed after thyroid hormone levels normalize. Similarly, cats with CKD may develop hypertension that requires treatment, and antihypertensive therapy can affect renal function and electrolyte balance. The interplay between these conditions requires careful monitoring and adjustment of treatment protocols.

Owner Observation: Recognizing Subtle Changes

The Value of a Daily Log

Owners are the first line of defense in detecting changes in their cat's condition. Maintaining a daily log of key parameters can provide invaluable information to the veterinary team and help identify trends before they become emergencies. A simple notebook or smartphone app can track the following:

• Water intake: Measure the amount of water added to the bowl each morning and the amount remaining the next day. A cat drinking more than 100 mL per kilogram of body weight per day is considered polydipsic.
• Food intake: Record the amount of food offered and the amount consumed at each meal. Note any changes in preference for specific foods or textures.
• Urination frequency and volume: Observe the litter box for clump size and frequency of use. An increase in the number of clumps or the size of clumps may indicate polyuria.
• Defecation frequency: As noted in the literature, CKD cats defecate less frequently than healthy cats [8]. A decrease in defecation frequency or the passage of hard, dry stools may indicate constipation.
• Body weight: Weekly weighing using a baby scale is recommended. A 5% loss over one month warrants veterinary attention.
• Behavioral changes: Note any increase in hiding, vocalization, or aggression, which may indicate pain or nausea. Also observe for changes in grooming habits, such as a greasy or matted coat.

Recognizing Pain and Nausea

Cats are masters at hiding discomfort, but subtle signs of pain and nausea are often present in CKD. These may include:

• Lip licking or smacking: A common sign of nausea in cats.
• Excessive salivation: May indicate oral ulcerations or nausea.
• Hiding or decreased social interaction: Cats in pain or discomfort often seek solitude.
• Postural changes: A hunched posture or reluctance to jump onto furniture may indicate abdominal pain or weakness.
• Head pressing: Pressing the head against walls or furniture can indicate severe metabolic disturbances or hypertensive encephalopathy.

When to Seek Emergency Care

Owners should be provided with clear guidelines for when to seek emergency veterinary care. Red flags include:

• Complete anorexia for more than 24 hours, which risks hepatic lipidosis.
• Vomiting that prevents oral medication or fluid intake.
• Sudden weakness or collapse, which may indicate severe anemia, hyperkalemia, or hypertensive crisis.
• Seizures or sudden blindness, which require immediate blood pressure assessment.
• Inability to urinate, which suggests urinary obstruction.
• Severe dehydration with skin tenting, sunken eyes, and dry mucous membranes.

Prevention: Evidence-Based Strategies

The Role of Annual Wellness Screening

The most effective strategy for managing feline CKD is early detection through annual wellness screening. For cats over 7 years of age, screening should include serum biochemistry with creatinine and SDMA, complete urinalysis with urine specific gravity and UPC, and blood pressure measurement. These tests can identify CKD in its earliest stages, when intervention is most likely to slow progression. The use of SDMA allows for detection months to years before creatinine becomes elevated, providing a window of opportunity for dietary modification and monitoring.

Breed-Specific Screening

Persian cats and related breeds, including Himalayans and Exotic Shorthairs, are at increased risk for polycystic kidney disease due to a specific mutation in the PKD1 gene [11]. Breeders should screen breeding cats for this mutation using genetic testing or ultrasound before including them in a breeding program. Affected cats should be removed from breeding to reduce the prevalence of this condition. Owners of Persian cats should be aware of the risk and discuss screening with their veterinarian, even if the cat appears healthy.

Dental Health and Systemic Inflammation

Periodontal disease is a source of chronic systemic inflammation that may contribute to renal injury. The inflammatory mediators released from infected periodontal tissues can promote oxidative stress and endothelial dysfunction, both of which are implicated in the pathogenesis of CKD. Regular dental prophylaxis, including professional cleaning under anesthesia and home dental care such as tooth brushing or dental diets, may reduce this inflammatory burden. While direct evidence linking dental disease to CKD progression in cats is limited, maintaining good oral health is a reasonable component of a comprehensive preventive care plan.

Avoiding Nephrotoxins

Owner education about nephrotoxins is a critical preventive measure. Lilies (Lilium and Hemerocallis species) are highly nephrotoxic to cats, and even ingestion of a small amount of pollen or a single petal can cause acute kidney injury. Owners should be advised to remove lilies from their homes and gardens. Non-steroidal anti-inflammatory drugs should be used only under veterinary guidance and at the lowest effective dose for the shortest duration. Aminoglycoside antibiotics should be avoided in cats with preexisting renal impairment. Ethylene glycol, found in antifreeze, is another potent nephrotoxin, and owners should ensure that antifreeze products are stored securely and that any spills are cleaned up immediately.

Special-Population Considerations

The Geriatric Cat

The majority of cats with CKD are geriatric, and management must account for the unique challenges of this population. Geriatric cats often have multiple comorbidities, including hyperthyroidism, diabetes mellitus, hypertension, and osteoarthritis. Polypharmacy is common, and drug interactions must be carefully considered. For example, the use of amlodipine for hypertension may cause gingival hyperplasia in some cats, and the use of methimazole for hyperthyroidism can cause gastrointestinal upset that may be mistaken for uremic signs. Additionally, geriatric cats may have difficulty accessing food and water bowls due to arthritis, and environmental modifications such as raised bowls and low-sided litter boxes can improve quality of life.

The Young Cat with CKD

While CKD is most common in older cats, it can occur in younger animals. In these cases, a thorough diagnostic workup is essential to identify potentially reversible causes. Polycystic kidney disease should be suspected in Persian and related breeds. Renal dysplasia, a congenital condition in which the kidneys fail to develop normally, can cause CKD in young cats. Infectious causes such as feline infectious peritonitis or leptospirosis should also be considered. Young cats with CKD may have a longer life expectancy than older cats, but they also face a longer period of disease management and may develop complications such as hypertension and proteinuria at an earlier age.

The Cat with Acute-on-Chronic Kidney Disease

Acute-on-chronic kidney disease occurs when a cat with preexisting CKD experiences an acute insult that causes rapid deterioration in renal function. Common triggers include dehydration from vomiting or diarrhea, urinary tract infection, ureteral obstruction, and exposure to nephrotoxins. These cats present with severe azotemia, often with creatinine levels exceeding 5.0 mg/dL, and may require intensive care including intravenous fluid therapy, antiemetics, and nutritional support. Machine learning algorithms using creatinine at 48 hours and spontaneous feeding status can predict short-term survival in these cases [4]. Owners should be aware that acute-on-chronic episodes can be life-threatening but that aggressive treatment may allow the cat to return to its baseline level of function.

The Cat with Concurrent Hyperthyroidism

The management of CKD in cats with concurrent hyperthyroidism requires a careful balancing act. Hyperthyroidism increases GFR, which can lower creatinine and mask the severity of CKD. Treatment of hyperthyroidism with methimazole or radioactive iodine reduces GFR, which can unmask CKD and cause a rise in creatinine. Therefore, cats with hyperthyroidism should have their renal function reassessed after thyroid hormone levels normalize. In some cases, the cat may develop clinically significant CKD after treatment, and the owner must be prepared for this possibility. The decision to treat hyperthyroidism should be made in consultation with a veterinarian, weighing the benefits of controlling hyperthyroidism against the potential for worsening renal function.

Prognosis: Beyond the Numbers

Individual Variability

While median survival times provide a general framework for prognosis, individual outcomes vary widely. Some cats in IRIS Stage 2 live for 4 to 5 years with appropriate management, while others progress more rapidly. The rate of progression is influenced by factors such as proteinuria status, blood pressure control, phosphate management, and the presence of concurrent disease. Cats with persistent proteinuria (UPC > 0.4) have a worse prognosis than those without proteinuria, and aggressive management of proteinuria with ACE inhibitors or ARBs can improve outcomes [13]. Similarly, cats with well-controlled hypertension have better outcomes than those with persistent hypertension.

The Role of FGF-23 in Prognostication

Plasma FGF-23 concentration is a powerful predictor of survival in cats with CKD, independent of creatinine, proteinuria, and blood pressure [15]. Cats with higher FGF-23 concentrations have shorter survival times, even when other parameters are similar. While FGF-23 measurement is not yet widely available, it is increasingly used in referral settings to identify cats at highest risk for rapid progression. These cats may benefit from more aggressive phosphate restriction and closer monitoring.

Quality of Life Assessment

Ultimately, the goal of CKD management is to maintain quality of life for as long as possible. Owners should be encouraged to assess their cat's quality of life regularly using a simple scale that considers factors such as appetite, activity level, grooming, social interaction, and comfort. When quality of life declines despite maximal therapy, euthanasia may be the most humane option. The veterinary team should support owners through this difficult decision and provide guidance on when it may be appropriate.

The Importance of Owner Education and Support

Managing a cat with CKD is a long-term commitment that requires significant owner involvement. Owners must be prepared to administer medications, monitor their cat's condition, and make dietary and environmental modifications. The veterinary team should provide clear, written instructions and be available to answer questions and address concerns. Support groups and online resources can also be helpful for owners who are navigating the challenges of CKD management. With appropriate care, many cats with CKD can enjoy a good quality of life for months to years after diagnosis.

Frequently Asked Questions

1. What are the first signs of kidney disease in cats? The earliest signs are increased thirst (polydipsia) and increased urination (polyuria), followed by weight loss, poor coat quality, and reduced appetite.

2. How is chronic kidney disease staged in cats? CKD is staged using the IRIS system, which classifies disease into four stages based on fasting serum creatinine and SDMA levels, with substages for proteinuria and hypertension.

3. Can kidney disease in cats be reversed? No, CKD is irreversible. However, early detection and appropriate management can slow progression, control complications, and maintain quality of life for months to years.

4. What should I feed a cat with kidney disease? A veterinary-prescribed renal diet that is restricted in phosphorus and protein, supplemented with omega-3 fatty acids, B vitamins, and potassium. Always transition gradually.

5. How often should a cat with kidney disease see the vet? Stable cats in IRIS Stage 2 should be rechecked every 3-6 months. Cats in Stage 3 or 4 should be seen every 1-2 months, or sooner if clinical signs worsen.

6. Is proteinuria dangerous in cats with CKD? Yes, persistent proteinuria (UPC > 0.4) is a negative prognostic indicator and accelerates disease progression. It should be managed with ACE inhibitors or ARBs.

7. Can I give my cat subcutaneous fluids at home? Yes, with veterinary guidance and training. Subcutaneous fluids help maintain hydration and reduce uraemic toxins. Typical doses range from 100-150 mL every 1-3 days.

8. What is the life expectancy of a cat with kidney disease? Life expectancy varies by stage at diagnosis: Stage 2 cats often live 2-3 years, Stage 3 cats 1-2 years, and Stage 4 cats 3-6 months. Individual outcomes depend on management and concurrent conditions.

Related Veterinary Guides

• Feline Hyperthyroidism: Diagnosis and Management
• Feline Diabetes Mellitus: A Practical Guide
• Feline Lower Urinary Tract Disease (FLUTD)
• Hypertension in Cats: Detection and Treatment
• Geriatric Cat Wellness: Screening and Preventive Care

References

[1] Carmen Ledesma-Feliciano, R. Troyer, Xin Zheng et al. Feline Foamy Virus Infection: Characterization of Experimental Infection and Prevalence of Natural Infection in Domestic Cats with and without Chronic Kidney Disease. Viruses. 2019. https://www.semanticscholar.org/paper/708330752dfbcdd2731c67c7ed3263d1a911241e

[2] J. Quimby, T. Webb, E. Randall et al. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats. Journal of feline medicine and surgery. 2016. https://www.semanticscholar.org/paper/d40b0515d67e843c8d1a51bf99ba9c201f0f2dfb

[3] Huiyuan Qi, Kodzue Kinoshita, Takashi Mori et al. Age estimation using methylation-sensitive high-resolution melting (MS-HRM) in both healthy felines and those with chronic kidney disease. Scientific Reports. 2021. https://www.semanticscholar.org/paper/3cf9e5e67afeae392b898be9f6e622a7959568f6

[4] Jade Renard, M. Faucher, A. Combes et al. Machine-learning algorithm as a prognostic tool in non-obstructive acute-on-chronic kidney disease in the cat. Journal of feline medicine and surgery. 2021. https://www.semanticscholar.org/paper/0b670895ba19b8e8ae95e5404bb5ea89a7a4de0d

[5] K. McCallum, Samuel C. B. Stubbs, N. Hope et al. Detection and seroprevalence of morbillivirus and other paramyxoviruses in geriatric cats with and without evidence of azotemic chronic kidney disease. Journal of Veterinary Internal Medicine. 2018. https://www.semanticscholar.org/paper/834ed855ccbdc049bb68a63802c03c8b45d00192

[6] J. Lawson, J. Elliott, C. Wheeler-Jones et al. Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury. The Veterinary Journal. 2015. https://www.semanticscholar.org/paper/ed8ec57ddc466ce9aaf331bdc46e143c62527a25

[7] Samuel Charles, Ricarda Süssenberger, Terry Settje et al. Use of molidustat, a hypoxia‐inducible factor prolyl hydroxylase inhibitor, in chronic kidney disease‐associated anemia in cats. Journal of Veterinary Internal Medicine. 2023. https://www.semanticscholar.org/paper/3f18a0c01ab16ec2332d91375d2bc66ed33957e2

[8] Sarah E. Jones, J. Quimby, S. Summers et al. Survey of defecation habits in apparently healthy and chronic kidney disease cats. Journal of feline medicine and surgery. 2021. https://www.semanticscholar.org/paper/ed8f24da030befffee0db75e06d6f5937bab1541

[9] Cathy A. Brown, D. Rissi, Vanna M Dickerson et al. Chronic Renal Changes After a Single Ischemic Event in an Experimental Model of Feline Chronic Kidney Disease. Veterinary Pathology-Supplement. 2019. https://www.semanticscholar.org/paper/3252fd57bd49b3fac2192f907b81211228f2d1ca

[10] V. Biourge, S. Delmotte, A. Feugier et al. An artificial neural network‐based model to predict chronic kidney disease in aged cats. Journal of Veterinary Internal Medicine. 2020. https://www.semanticscholar.org/paper/f0eb74c712e076830b6fb3d1360f14c963478b61

[11] N. Bilgen, Merve Bişkin Türkmen, Bengi Çınar Kul et al. Prevalence of PKD1 gene mutation in cats in Turkey and pathogenesis of feline polycystic kidney disease. Journal of Veterinary Diagnostic Investigation. 2020. https://www.semanticscholar.org/paper/e112ff6d5dcc789e8bd59e340c0f7b452d655e4f

[12] M. Takenaka, A. Iio, R. Sato et al. A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 2017. https://www.semanticscholar.org/paper/f8e8bb9f978ff01b8edfa09db19df872dfb3a997

[13] Shelly L Vaden, J. Elliott. Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease. The Veterinary clinics of North America. Small animal practice. 2016. https://www.semanticscholar.org/paper/7747067951341e5457384ab47a5a242294f66d4b

[14] R. Jepson. Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats. The Veterinary clinics of North America. Small animal practice. 2016. https://www.semanticscholar.org/paper/267563dd60cf3f023efd2e727aadd06a5d6f1606

[15] R. Geddes, J. Elliott, H. Syme. Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 2015. https://www.semanticscholar.org/paper/6248ff43cefe7cf05f6f6b5425a74b58f5506544

[16] Yoshihiko Yu, Kate L. Shumway, J. Matheson et al. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model. BMC Nephrology. 2019. https://www.semanticscholar.org/paper/c2a8f5acd898cbf8368b9a6f4d8bff0a4e36eec4

[17] C. Schmiedt, Keren G Beita, Bianca N Lourenço et al. A remnant kidney surgery model in cats induces acute and chronic outcomes that mimic spontaneous chronic kidney disease. American Journal of Veterinary Research. 2023. https://www.semanticscholar.org/paper/21204f692a27988bf063cb834fbb39d4eb8d29d0

[18] A. Hishida, R. Okada, M. Naito et al. Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study. Journal of clinical biochemistry and nutrition. 2013. https://www.semanticscholar.org/paper/2115207bec42b49eb0fc98961577476085955fe3

[19] Bianca N Lourenço, A. Coleman, C. Schmiedt et al. Profibrotic gene transcription in renal tissues from cats with ischemia-induced chronic kidney disease. American Journal of Veterinary Research. 2020. https://www.semanticscholar.org/paper/e5abb03046e2abaeaa189b7f4b8e19a1945f24ba

[20] Bianca N Lourenço, A. Coleman, J. Tarigo et al. Evaluation of profibrotic gene transcription in renal tissues from cats with naturally occurring chronic kidney disease. Journal of Veterinary Internal Medicine. 2020. https://www.semanticscholar.org/paper/407745d9bf0cd6c2499dbd19fcd2c6b64b017d12